China Earlier this year, PharmaBoardroom highlighted five of the most innovative and important biotech companies making waves in the world’s second-largest pharmaceutical market, China. Here, we pick out five more firms looking to crack both the Chinese and international markets. EpimAB Biotherapeutics Founded in 2015, EpimAb Biotherapeutics is a privately owned…
Cannabis GW Pharmaceuticals reports that sales of its CBD drug Epidiolex more than doubled in the second quarter of 2019, demonstrating that cannabinoid-based medicines can be highly profitable and potentially blazing a trail for other pharmaceutical companies to follow. With more and more countries moving to legalise medical cannabis and…
Puerto Rico Leobardo Hidalgo, who lived in Puerto Rico as a child, recently came back to the island to head commercial operations at the local BMS affiliate, which has been performing remarkably well. He highlights a portfolio of transformational medicines matched with the local team’s patient-centric approach and knowledge of the ecosystem…
Sweden Medivir is a Swedish biotech company focusing on the development and commercialization of innovative treatments for cancers of high unmet medical need. Last October, Dr Uli Hacksell was appointed CEO to reorganize the company in order to focus resources on the clinical development of Medivir’s projects. He presents the progress…
Thailand Dr Somvong Tragoonrung, executive director of BIOTEC, one of the first biotechnology-focused research institutes in Thailand, highlights their current research in biotechnology and genomics projects, as well as the local and international collaboration they have in place to further develop the strengths of Thailand in the field. Currently, estimations…
China Dr Kai Lamottke, co-founder and MD of Bicoll GmbH, Munich, and since 2001, GM and board member of Bicoll Biotechnology (Shanghai) Co. Ltd discusses Bicoll’s presence in both the Chinese and European markets, its unique Bicoll Plant ProfilesTM (fine fractions derived from plant extracts fractionated by Bicoll’s innovative isolation system…
Taiwan Shing-Mou Lee, founder and president of EMO Biomedicine, the leading CDMO provider of cell-based products in Taiwan, discusses the major regulatory and maturation trends in the region and shares his future strategy for expanding the company’s position in the sector. One of EMO’s missions is to help the government…
Spain In what is a highly competitive and crowded women’s health field in Spain, smaller players are having to be increasingly focused and specialised to carve out a market share. The [Spanish women’s health] market is very competitive since there are many companies and the sector is overwhelmingly a business…
Europe Dentons Germany’s Peter Homberg outlines the key requirements that companies need to fulfil in order to import medical cannabis into Germany and how attitudes and legislation on the topic are shifting across Europe. In order to import medicinal cannabis from another country to Germany, like many other countries, the…
Taiwan Taiwan’s biotechnology industry was valued at USD 3.3 billion in 2016, representing around 26 percent of the island’s total biopharmaceutical market, along with pharmaceuticals and medical devices. Made with Visme Infographic Maker The stock market capitalization of Taiwan’s biotech sector soared from USD 3.4 billion in 2007 to USD…
Taiwan HB Chen, president of TaiwanBio Therapeutics, introduces the innovative stem cell company and elaborates on their patented cell expansion technique for the production of mesenchymal stem cells (MSC). Chen then goes on to discuss the company’s innovative pipeline of stem cell therapies. Overall, our offering will be a great…
Taiwan Taiwan boasts a booming life sciences sector and is striving to innovate through collaboration. Here we present five of the key executives and stakeholders who are aiming to drive the island’s life sciences sector forward. Johnsee Lee – Chairman, Taiwan Bio Industry Organization Dr Johnsee Lee holds a number…
See our Cookie Privacy Policy Here